Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search:
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
language:"English"
product_txtF_mv:"National Center for Biotechnology Information"
dewey-ones:"700 - The arts; fine & decorative arts"
author_facet:"CADTH Canadian Drug Expert Committee"
Showing
1
-
17
of
17
Search:
''
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
2
CADTH Canadian Drug Expert Committee recommendation: Rivaroxaban (Xarelto -- Bayer Inc.) : indication : coronary artery disease with or without peripheral artery disease
Published 2018
CADTH
Read Now
3
CADTH Canadian Drug Expert Committee recommendation: Baricitinib (Olumiant -- Eli Lilly Canada Inc.) : indication : for use in combination with methotrexate (MTX) for the treatment...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
4
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
5
CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
6
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
Read Now
7
CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
8
CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
9
Clinical review report: Upadacitinib (Rinvoq) (AbbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
10
CADTH Canadian drug expert committee recommendation: Upadacitinib (Rinvoq -- abbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthri...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
11
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
12
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
Read Now
13
CADTH Canadian Drug Expert Committee recommendation: Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) : indication: in adults, as an adjunct to standard of care therapy, for the...
Published 2021
Canadian Agency for Drugs and Technologies in Health
Read Now
14
CADTH Canadian Drug Expert Committee recommendation: Rivaroxaban (Xarelto -- Bayer Inc.) : indication : coronary artery disease with or without peripheral artery disease
Published 2018
CADTH
Read Now
15
Clinical review report: Upadacitinib (Rinvoq) (AbbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
16
CADTH Canadian Drug Expert Committee recommendation: Baricitinib (Olumiant -- Eli Lilly Canada Inc.) : indication : for use in combination with methotrexate (MTX) for the treatment...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
17
CADTH Canadian drug expert committee recommendation: Upadacitinib (Rinvoq -- abbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthri...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Back
Narrow Search
Remove Filters
Clear Filter
Language: English
Clear Filter
Collection: National Center for Biotechnology Information
Clear Filter
Classification: 700 - The arts; fine & decorative arts
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Year of Publication
From:
To:
Classification
700 - The arts; fine & decorative arts
610 - Medicine & health
15
330 - Economics
8
140 - Specific philosophical schools
4
Language
English
Collection
National Center for Biotechnology Information
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
14
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=language%3A%22English%22&filter%5B%5D=product_txtF_mv%3A%22National+Center+for+Biotechnology+Information%22&filter%5B%5D=dewey-ones%3A%22700+-+The+arts%3B+fine+%26+decorative+arts%22&filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&type=AllFields
Send by Email
×
Loading...